Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics Statistics

Total Valuation

APRE has a market cap or net worth of $10.90 million. The enterprise value is -$35.55 million.

Market Cap	10.90M
Enterprise Value	-35.55M

Important Dates

The last earnings date was Wednesday, May 13, 2026, before market open.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

APRE has 11.98 million shares outstanding. The number of shares has increased by 46.20% in one year.

Current Share Class	11.98M
Shares Outstanding	11.98M
Shares Change (YoY)	+46.20%
Shares Change (QoQ)	+91.02%
Owned by Insiders (%)	11.69%
Owned by Institutions (%)	10.28%
Float	7.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	88.52
Forward PS	n/a
PB Ratio	0.27
P/TBV Ratio	0.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.92

Current Ratio	8.92
Quick Ratio	8.77
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -40.40% and return on invested capital (ROIC) is -26.57%.

Return on Equity (ROE)	-40.40%
Return on Assets (ROA)	-23.18%
Return on Invested Capital (ROIC)	-26.57%
Return on Capital Employed (ROCE)	-29.73%
Weighted Average Cost of Capital (WACC)	12.61%
Revenue Per Employee	$15,412
Profits Per Employee	-$1.49M
Employee Count	8
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.51% in the last 52 weeks. The beta is 1.52, so APRE's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	-45.51%
50-Day Moving Average	0.83
200-Day Moving Average	1.09
Relative Strength Index (RSI)	52.68
Average Volume (20 Days)	197,573

Short Selling Information

The latest short interest is 103,019, so 0.86% of the outstanding shares have been sold short.

Short Interest	103,019
Short Previous Month	109,910
Short % of Shares Out	0.86%
Short % of Float	1.47%
Short Ratio (days to cover)	0.13

Income Statement

In the last 12 months, APRE had revenue of $123,296 and -$11.95 million in losses. Loss per share was -$1.37.

Revenue	123,296
Gross Profit	-6.92M
Operating Income	-12.58M
Pretax Income	-11.95M
Net Income	-11.95M
EBITDA	-12.56M
EBIT	-12.58M
Loss Per Share	-$1.37

Balance Sheet

The company has $46.47 million in cash and n/a in debt, with a net cash position of $46.47 million or $3.88 per share.

Cash & Cash Equivalents	46.47M
Total Debt	n/a
Net Cash	46.47M
Net Cash Per Share	$3.88
Equity (Book Value)	42.32M
Book Value Per Share	3.47
Working Capital	41.95M

Cash Flow

Operating Cash Flow	-12.02M
Capital Expenditures	n/a
Depreciation & Amortization	21,714
Net Borrowing	n/a
Free Cash Flow	-12.02M
FCF Per Share	-$1.00

Margins

Gross Margin	n/a
Operating Margin	-10,202.01%
Pretax Margin	-9,696.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-46.20%
Shareholder Yield	-46.20%
Earnings Yield	-109.53%
FCF Yield	-110.13%

Analyst Forecast

The average price target for APRE is $4.30, which is 372.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.30
Price Target Difference	372.53%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	122.39%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1